Wednesday, June 19, 2002 2:11:28 PM
BioShield Launches 12 New Products and Initiates National Campaign to Obtain New Resellers and Distributors
ATLANTA, June 19 /PRNewswire-FirstCall/ -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI) announced today the development of twelve new products ready for market and has initiated a campaign to put in place nationwide distribution.
BioShield Technologies has devoted considerable time and expense to create a suite of products to serve large multi-billion dollar industries and several market niches with the potential of becoming one of the nation's leading suppliers of antimicrobial and antiviral products.
BioShield is proud to announce its twelve new products that are ready for market:
* BST 1870: Medical-Grade antimicrobial/antibacterial compound. Market
focus of BST 1870 is the $2 trillion worldwide healthcare and medical
sector.
* AM REM: EPA Approved. Bio-Remediation antibacterial/antimicrobial
compound. Market focus for this product is the bio-remediation
industry.
* BST C503: EPA Approved. Product focus is used as a deordorizer, anti-
static agent and antimicrobial barrier for application on carpets and
rugs.
* BST H502: EPA Approved. Product's focus is to be utilized as a
surfactant or coating on a diverse array of hard surfaces.
* BST F501: EPA Approved. BST F501 is designed to be utilized in
filtration systems for both water and air purification.
* BST 022: Anti Corrosion product to be used on a wide variety of
surfaces to be utilized in the specialty coatings industry.
* BST ANTISTAT: Antistatic Agent to be used as a surfactant on a diverse
array of surfaces.
* BST LUBE-EX: Lubricant with antimicrobial properties to be utilized in
environments where lubricants must be bacteria free. Applications
typically sought in the oil and equipment industry
* BST - AS 048: EPA Approved Anti Slime agent to be used within the $800
million pulp and paper industry and other industries where slime is a
problem in large production facilities that deal with pulp, paper,
food, and natural resources.
* BST-7: Odor counteractant to be utilized in both consumer and
industrial applications in a large variety of industries and
applications.
* BST CD530: Antimicrobial agent specifically designed for concrete
applications. Particularly focused in the building industry, which is
estimated at $1 Billion.
* MB M100: De-Odorizing Clear Coating antibacterial/antimicrobial agent.
Can be utilized across numerous industries and applications and
Management stated, "BioShield has been on track to completely turn around the company from a financial standpoint, an operational standpoint and from our product focus and distribution models. One of the last major objectives for the Company was to create a suite of products that can be utilized in a wide variety of industries with a vast array of application. This latest product launch accomplishes that and we've embarked upon an aggressive growth campaign to sign up new distributors and resellers on a national scale. BioShield's new and existing product suite not only addresses many large multi-billion dollar industries and niche markets, it also puts BioShield in position to quickly ramp up new revenue, expand our reseller base, and creates the platform and potential to achieve growth in the near future."
About Bioshield Technologies, Inc.:
BioShield Technologies, Inc., is a Norcross, Georgia-based emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV, on contact and can remain active for extended time periods. To date BioShield has received three US patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.
Further information on BioShield and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653, Tim Moses.
Safe Harbor/Forward-looking Statements;
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of BioShield; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of BioShield Technologies, Inc.
MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X12566654
SOURCE BioShield Technologies, Inc.
/CONTACT: Tim Moses of BioShield Technologies, Inc., +1-770-925-3653/
/Web site: http://www.bioshield.net/
(BSTI)
The best weapon against "fear" is "facts"!!
ATLANTA, June 19 /PRNewswire-FirstCall/ -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI) announced today the development of twelve new products ready for market and has initiated a campaign to put in place nationwide distribution.
BioShield Technologies has devoted considerable time and expense to create a suite of products to serve large multi-billion dollar industries and several market niches with the potential of becoming one of the nation's leading suppliers of antimicrobial and antiviral products.
BioShield is proud to announce its twelve new products that are ready for market:
* BST 1870: Medical-Grade antimicrobial/antibacterial compound. Market
focus of BST 1870 is the $2 trillion worldwide healthcare and medical
sector.
* AM REM: EPA Approved. Bio-Remediation antibacterial/antimicrobial
compound. Market focus for this product is the bio-remediation
industry.
* BST C503: EPA Approved. Product focus is used as a deordorizer, anti-
static agent and antimicrobial barrier for application on carpets and
rugs.
* BST H502: EPA Approved. Product's focus is to be utilized as a
surfactant or coating on a diverse array of hard surfaces.
* BST F501: EPA Approved. BST F501 is designed to be utilized in
filtration systems for both water and air purification.
* BST 022: Anti Corrosion product to be used on a wide variety of
surfaces to be utilized in the specialty coatings industry.
* BST ANTISTAT: Antistatic Agent to be used as a surfactant on a diverse
array of surfaces.
* BST LUBE-EX: Lubricant with antimicrobial properties to be utilized in
environments where lubricants must be bacteria free. Applications
typically sought in the oil and equipment industry
* BST - AS 048: EPA Approved Anti Slime agent to be used within the $800
million pulp and paper industry and other industries where slime is a
problem in large production facilities that deal with pulp, paper,
food, and natural resources.
* BST-7: Odor counteractant to be utilized in both consumer and
industrial applications in a large variety of industries and
applications.
* BST CD530: Antimicrobial agent specifically designed for concrete
applications. Particularly focused in the building industry, which is
estimated at $1 Billion.
* MB M100: De-Odorizing Clear Coating antibacterial/antimicrobial agent.
Can be utilized across numerous industries and applications and
Management stated, "BioShield has been on track to completely turn around the company from a financial standpoint, an operational standpoint and from our product focus and distribution models. One of the last major objectives for the Company was to create a suite of products that can be utilized in a wide variety of industries with a vast array of application. This latest product launch accomplishes that and we've embarked upon an aggressive growth campaign to sign up new distributors and resellers on a national scale. BioShield's new and existing product suite not only addresses many large multi-billion dollar industries and niche markets, it also puts BioShield in position to quickly ramp up new revenue, expand our reseller base, and creates the platform and potential to achieve growth in the near future."
About Bioshield Technologies, Inc.:
BioShield Technologies, Inc., is a Norcross, Georgia-based emerging growth company focused in biotechnology and antimicrobial products. Its core business is committed to the discovery, development, marketing and sale of surface-modifying antimicrobial and biostatic products. The company's antimicrobial technology is a revolutionary alternative to conventional sanitizers, disinfectants, bleaches, biocides or preservatives primarily because it kills bacteria, including HIV, on contact and can remain active for extended time periods. To date BioShield has received three US patents and eight EPA registrations, including the first U.S. germ killer and disinfectant against Salmonella cholerasuis, Staphylococcus aureus and other microorganisms. The company has developed several alliances in different industries, such as healthcare, textiles and storm water.
Further information on BioShield and its line of products can be found by visiting the firm's web site at http://www.bioshield.com , or by calling 1-770-925-3653, Tim Moses.
Safe Harbor/Forward-looking Statements;
Statements in this news release that are not historical are forward- looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in any forward-looking statements, all of which are difficult to predict and many of which are beyond the control of the company, including areas such as: developing technologies; dependence on collaborative partners; the inherent complexity and uncertainty regarding the development of products; early-stage development of BioShield; the result of research and development efforts; future capital needs; uncertainty of additional funding; government regulations; and other factors which are detailed in the company's periodic reports and registration statements filed with the Securities and Exchange Commission. BioShield does not undertake to revise or update any forward-looking statement to reflect events or circumstances that may arise after the date hereof. BioShield is a trademark of BioShield Technologies, Inc.
MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X12566654
SOURCE BioShield Technologies, Inc.
/CONTACT: Tim Moses of BioShield Technologies, Inc., +1-770-925-3653/
/Web site: http://www.bioshield.net/
(BSTI)
The best weapon against "fear" is "facts"!!
The best weapon against "fear" is "facts"!!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
